Paul Tudor Jones Inovio Pharmaceuticals, Inc. Transaction History

Tudor Investment Corp Et Al

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$0.38 - $0.58 $124,435 - $189,928	-327,463 Reduced 59.16%	226,021 $88,000
Q2 2023 Aug 14, 2023	BUY	$0.39 - $0.94 $163,278 - $393,544	418,664 Added 310.54%	553,484 $249,000
Q1 2023 May 15, 2023	SELL	$0.79 - $1.91 $3,615 - $8,742	-4,577 Reduced 3.28%	134,820 $111,000
Q4 2022 Feb 14, 2023	BUY	$1.41 - $2.5 $196,549 - $348,492	139,397 New	139,397 $217,000
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $211,390 - $584,260	146,799 Added 295.17%	196,533 $340,000
Q1 2022 May 16, 2022	SELL	$2.97 - $5.2 $814,474 - $1.43 Million	-274,234 Reduced 84.65%	49,734 $179,000
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $250,068 - $373,850	50,114 Added 18.3%	323,968 $1.62 Million
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $1.25 Million - $1.69 Million	174,133 Added 174.62%	273,854 $1.96 Million
Q2 2021 Aug 16, 2021	BUY	$6.23 - $10.03 $621,261 - $1 Million	99,721 New	99,721 $924,000
Q4 2020 Feb 16, 2021	SELL	$8.5 - $12.85 $172,558 - $260,867	-20,301 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.57 - $27.05 $24,987 - $70,627	2,611 Added 14.76%	20,301 $235,000
Q2 2020 Aug 14, 2020	SELL	$7.14 - $31.69 $35,857 - $159,147	-5,022 Reduced 22.11%	17,690 $477,000
Q1 2020 May 15, 2020	BUY	$2.98 - $14.09 $67,681 - $320,012	22,712 New	22,712 $169,000
Q4 2017 Feb 14, 2018	SELL	$4.13 - $6.68 $206,500 - $334,000	-50,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.36 - $6.37 $268,000 - $318,500	50,000	50,000 $317,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.